GlassScriptPhysician profile
Emily F Gubert
NPI 1134343296
$1,948.16
in general payments reported to CMS, 2019-2025
20 companies · $27.64 in 2025
The $27.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $368 · 2021: $12.17 · 2022: $88.92 · 2023: $345 · 2024: $473 · 2025: $27.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.26 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.64 | 2019 | |
| Celularity INC. | $300.00 | 2020 | |
| Sumitomo Pharma America, INC. | $235.48 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $161.92 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $155.13 | 2023-2024 | |
| Daiichi Sankyo INC. | $135.64 | 2019-2023 | Injectafer |
| Hologic Sales and Service, LLC | $112.64 | 2021-2023 | Coolseal Generator, Acessa Provu System, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $63.94 | 2023-2024 | Phexxi |
| Roche Diagnostics Corporation | $53.34 | 2019 | |
| Allergan, INC. | $52.47 | 2019-2020 | |
| Coopersurgical, INC. | $52.33 | 2022-2023 | Paragard T 380a |
| Amgen INC. | $47.77 | 2019-2023 | Prolia, Evenity |
| Exeltis, USA INC. | $45.32 | 2023-2024 | Slynd |
| Vertical Pharmaceuticals, LLC | $34.34 | 2019 | |
| Biogen, INC. | $27.64 | 2025 | Zurzuvae |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $27.26 | 2019-2020 | |
| Meditrina | $25.35 | 2023 | |
| Merck Sharp & Dohme LLC | $15.75 | 2019 | |
| Avion Pharmaceuticals | $14.76 | 2019 | |
| Organon LLC | $5.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Gubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.